Hepatitis C virus helicase/NTPase: an efficient expression system and new inhibitors

Area of Science:

• Biochemistry
• Virology

Background:

• Hepatitis C virus (HCV) non-structural protein 3 (NS3) is crucial for viral replication.
• Understanding NS3's enzymatic activities, NTPase and helicase, is key to developing antiviral strategies.

Purpose of the Study:

• To optimize the production of full-length HCV NS3 protein.
• To characterize the NTPase and helicase activities of NS3.
• To investigate the effects of NTP and pyrophosphate analogs on NS3 activity.

Main Methods:

• Optimized cell culture conditions for high-yield NS3 protein expression.
• Established and refined assays for measuring NS3 NTPase and helicase activities.
• Screened various nucleotide and pyrophosphate analogs as substrates and inhibitors.

Main Results:

• Achieved a yield of 6.5 mg/liter of cell culture for full-length NS3 protein.
• Identified two distinct modes for the helicase reaction: non-catalytic (enzyme excess) and catalytic (substrate excess).
• Imidodiphosphate strongly inhibited ATP-dependent helicase activity, while 2'-deoxythymidine 5'-phosphoryl-β,γ-hypophosphate showed minimal inhibition, potentially activating the enzyme.

Conclusions:

• Optimized methods facilitate robust study of HCV NS3 enzymatic functions.
• NS3 helicase activity can be modulated by substrate concentration, influencing its mechanism.
• Specific inhibitors like imidodiphosphate show potential for targeting HCV replication.